Updated clinical practice recommendations regarding the periprocedural use of GLP-1RAs and GLP-1/GIPRAs (April 2025)
Based on new evidence from clinical studies and to make recommendations clearer, clinical practice recommendations for patients taking GLP-1 RA and dual GLP-1/GIP RAs prior to anaesthesia or sedation have […]
August 2024: New ADS Guideline and Consensus Statement
Joint ADS/ANZSNM guideline for FDG PET/CT imaging in patients with type 1 and type 2 diabetes (August 2024) A joint guideline by the Australian Diabetes Society (ADS) and Australian and […]
Updated Australian Obesity Management Algorithm
Revised Australian Obesity Management Algorithm The Australian Diabetes Society (ADS) has updated the Australian Obesity Management Algorithm position statement. Download the updated Australian Obesity Management Algorithm Position Statement (July 2024) […]
Clinical Practice Recommendation On Periprocedural Use Of GLP-1/GIP Receptor Agonists (June 2024)
A consensus clinical practice recommendation endorsed by the Australian Diabetes Society (ADS), National Association of Clinical Obesity Services (NACOS), Gastroenterological Society of Australia (GESA) and Australian and New Zealand College […]
Updated T2D Management Algorithm
Revised Australian Type 2 Diabetes Glycaemic Management Algorithm The Australian Diabetes Society (ADS) has updated the Australian Type 2 Diabetes Glycaemic Management Algorithm diagram to reflect the recent Pharmaceutical Benefits […]
World Diabetes Day 2023
14th November 2023 World Diabetes Day is a global occasion on which people with diabetes, health professionals, diabetes advocates, media, the general public and government organisations unite to raise awareness […]
Roadmap to unite in the fight for change: ADS launches strategic plan 2023-27 with its united partners to reduce diabetes impact
Thank you for joining the conversation during National Diabetes Week. To end the week, we are launching our new strategic plan. The diabetes epidemic is one of the largest and […]
ADS Position Statement ‘Medical Certification of Persons with Insulin-treated Diabetes in the Aviation Industry’
This is the first ADS supported position statement to address medical certification of diabetes in the workplace. The main focus of this document is the aviation industry, but these guidelines […]
ADS-ANZCA Perioperative Diabetes and Hyperglycaemia Guidelines (Adults)
The prevalence of diabetes is rising and so too is the complexity of diabetes management. Modern perioperative management of patients with diabetes focuses on thorough pre-operative assessment and optimisation of […]
COVID 19 Updates
COVID-19 resources for Diabetes Health Professionals Follow-up survey on COVID-19 and diabetes in Australia (1 June, 2020) This is a follow-up survey to assist us to better understand what support […]
